Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 93-98 , March 2008

Are there effective new strategies for the treatment of acute and chronic GvHD?

  • Nelson J. Chao, MD, MBA (Professor of Medicine and Immunology)

      Affiliations

    • Corresponding Author InformationTel.: +1 919 668 1010; Fax: +1 919 668 1091.

References 

  1. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. Journal of Immunology. 1997;158:3037–3045
  2. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. Journal of Immunology. 2000;164:2180–2187
  3. Iwasato T, Yamagishi H. Novel excision products of T cell receptor gamma gene rearrangements and developmental stage specificity implied by the frequency of nucleotide insertions at signal joints. European Journal of Immunology. 1992;22:101–106
  4. Klein AK, Patel DD, Gooding ME, et al. T-Cell recovery in adults and children following umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation. 2001;7:454–466
  5. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690–695
  6. Chen BJ, Cui X, Sempowski GD, et al. Transfer of allogeneic CD62L-memory T cells without graft-versus-host disease. Blood. 2004;103:1534–1541
  7. Chen BJ, Cui X, Sempowski GD, et al. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344–4352
  8. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biology of Blood and Marrow Transplantation. 2006;12:252–266
  9. Zorn E, Miklos DB, Floyd BH, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. The Journal of Experimental Medicine. 2004;199:1133–1142
  10. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood. 2004;103:353–359
  11. Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006;108:756–762
  12. Fujii H, She K, Aslanian S, et al. Inflammatory markers and autoantibodies that correlate with early and late onset of new onset pediatric chronic graft-versus-host disease (GVHD). Blood. 2006;108:923a;[abstract #3232]
  13. Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998;395:284–288
  14. Lin Y, Lee H, Berg AH, et al. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. The Journal of Biological Chemistry. 2000;275:24255–24263
  15. Chow JC, Young DW, Golenbock DT, et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. The Journal of Biological Chemistry. 1999;274:10689–10692
  16. Rhee SH, Keates AC, Moyer MP, et al. MEK is a key modulator for TLR5-induced interleukin-8 and MIP3alpha gene expression in non-transformed human colonic epithelial cells. The Journal of Biological Chemistry. 2004;279:25179–25188
  17. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740–745
  18. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 2004;104:889–894

PII: S1521-6926(07)00103-X

doi: 10.1016/j.beha.2007.11.012

Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 93-98 , March 2008